PLUS THERAPEUTICS, INC. (PSTV) › Cash & EquivalentsPLUS THERAPEUTICS, INC. (PSTV) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $12.61M2009: $12.85M2010: $52.67M2011: $36.92M2012: $25.72M2013: $15.51M2014: $14.62M2015: $14.34M2016: $12.60M2017: $9.55M2018: $5.26M2019: $17.55M2020: $8.35M2021: $18.40M2022: $18.12M2023: $8.55M2024: $76.0K2025: $4.26M$4.26M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$4.26M+5500.0%2024$76.0K-99.1%2023$8.55M-52.8%2022$18.12M-1.5%2021$18.40M+120.5%2020$8.35M-52.4%2019$17.55M+233.6%2018$5.26M-44.9%2017$9.55M-24.2%2016$12.60M-12.1%2015$14.34M-1.9%2014$14.62M-5.7%2013$15.51M-39.7%2012$25.72M-30.3%2011$36.92M-29.9%2010$52.67M+309.7%2009$12.85M+1.9%2008$12.61M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share